INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 228 filers reported holding INSMED INC in Q1 2023. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,264,126 | +10.0% | 446,104 | -8.1% | 0.06% | +15.7% |
| Q2 2023 | $10,243,185 | +16.3% | 485,459 | -6.0% | 0.05% | +6.2% |
| Q1 2023 | $8,804,177 | -16.3% | 516,374 | -1.9% | 0.05% | -21.3% |
| Q4 2022 | $10,515,054 | +140.7% | 526,279 | +159.5% | 0.06% | +110.3% |
| Q3 2022 | $4,368,000 | +360.8% | 202,776 | +321.9% | 0.03% | +383.3% |
| Q2 2022 | $948,000 | +213.9% | 48,065 | +273.8% | 0.01% | +500.0% |
| Q1 2022 | $302,000 | -66.8% | 12,860 | -74.3% | 0.00% | -87.5% |
| Q4 2015 | $909,000 | -35.4% | 50,100 | -33.9% | 0.01% | -27.3% |
| Q3 2015 | $1,408,000 | -35.7% | 75,800 | -15.5% | 0.01% | -45.0% |
| Q2 2015 | $2,190,000 | -0.5% | 89,700 | -15.2% | 0.02% | +5.3% |
| Q1 2015 | $2,201,000 | +99.5% | 105,800 | +48.4% | 0.02% | +111.1% |
| Q4 2014 | $1,103,000 | +86.0% | 71,300 | +152.8% | 0.01% | +125.0% |
| Q1 2014 | $593,000 | – | 28,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |